How Pieces Technologies’ AI is Driving Clinical Efficiency

By Michael Awood

September 14, 2023

Significant progress is being made in healthcare by Pieces Technologies Inc.

Healthcare professionals use its Artificial Intelligence (AI) platform to manage cases, plan discharges, and reduce hospital stays. Recently, the AI wrote its one-millionth clinical summary – in just seven months. This displays the role and impact that AI can have in healthcare.

The Pieces system uses advanced technology and human help to ensure high accuracy while maintaining a hallucination rate of less than 0.1%. “Hallucinations” refer to instances where the AI produces incorrect or nonsensical outputs. However, Pieces shows great promise in this area with a considerable improvement compared to existing models. This high accuracy is further evidenced by the reduced need for edits in the system’s output.

The software is a trusted tool for healthcare professionals, supporting various clinical procedures and contributing to efforts aimed at reducing patient stay duration and readmission rates.
This achievement highlights the potential of applied clinical generative AI in healthcare delivery. Pieces Technologies has committed to safety, transparency, and accountability to improve healthcare outcomes and operations.

Pieces Technologies is leading the way in redefining healthcare through AI, achieving clinical efficiency and patient care. The system is set to be implemented in pediatric hospital environments soon, further expanding its impact. This highlights the importance of AI in healthcare, not to surpass benchmarks, but to enhance patient care and clinical outcomes.

 

Cover image source: PR Newswire. Link in the reference URL

Reference url

Recent Posts

preventive health costs
       

Prevention Valuation: Fund Health, Not Just Savings

💡 Is prevention really saving us money in healthcare?

In their thought-provoking article, “Can Prevention Save Money?”, Baicker and Chandra challenge the prevailing notion that preventive health measures always reduce costs. They argue that while prevention can enhance health outcomes, it often leads to increased spending upfront, and the key lies in evaluating these programs based on their cost-effectiveness instead of expecting them to save money outright.

Curious about the real financial implications of preventive care? Dive into the full analysis to uncover the nuances!

#SyenzaNews #HealthEconomics #costeffectiveness #healthcarepolicy

FDA AI Drug Approval
          

FDA AI Drug Approval

🚀 Are we on the brink of a new era in drug approval?

The FDA’s new AI initiative is set to reshape how we evaluate new therapies by dramatically speeding up the review process. With generative AI tools already cutting down review times from days to mere minutes, this breakthrough will not only enhance efficiency but also enable scientists to focus on more impactful work.

Curious about the implications for market access, patient outcomes, and health economics? Dive into the full article to explore how the future of pharmaceutical approvals is being transformed!

#SyenzaNews #regulatoryaffairs #AIinHealthcare #innovation

HCV treatment advancements
      

HCV Treatment Advancements: Atea Pharmaceuticals KOL Panel

🌍 Are we on the brink of a new era in Hepatitis C treatment?

Atea Pharmaceuticals is hosting a virtual KOL panel on May 14, 2025, featuring top experts discussing the challenges faced by HCV patients and sharing insights from the promising results of their Phase 2 study on bemnifosbuvir and ruzasvir. This could be a game-changer in advancing HCV treatments through ongoing Phase 3 trials.

Don’t miss out on how these developments might reshape the future landscape for HCV patients! Click to read more about the panel and the innovative therapies in the pipeline.

#SyenzaNews #biotechnology #HealthEconomics

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.